entertainment -WSS

entertainment

author：comprehensive 2025-09-02 22:25:35 - browse：87

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Humana CEO Bruce Broussard to step down in 2024

WSS

A fraught question for the kids of Alzheimer’s: Is it coming for us?

H5N1 virus can be tracked in retail milk, scientists say

What the Wegovy shortage looks like for doctors — and for patients

H5N1 bird flu outbreak: Second human case reported, in Michigan

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

knowledge

entertainment

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

H5N1 virus can be tracked in retail milk, scientists say

Apple is now the first public company to be valued at $3 trillion

ASCO eve: Let’s set the table for this year's meeting

Malaria cases in Florida and Texas: Here’s what you need to know

Takeaways from AdvaMed, the largest medical devices conference

Medicare details structure of new drug price negotiation program

Biogen joins immunology wave with $1.15 billion acquisition of HI

Medical leaders decry Supreme Court decision on affirmative action

Questions and answers about ramping up H5N1 bird flu vaccine

entertainment

Takeaways from AdvaMed, the largest medical devices conference

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Addressing health care workers' trauma can help fight burnout

Scrutiny of post

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Takeaways from AdvaMed, the largest medical devices conference

Wikipedia

Wikipedia

knowledge

explore